The Efficacy and Safety of Degarelix, a GnRH Antagonist: A 12-month, Multicentre, Randomized, Maintenance Dose-finding Phase II Study in Japanese Patients with Prostate Cancer (Q40291926)
Jump to navigation
Jump to search
scientific article published on March 28, 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Efficacy and Safety of Degarelix, a GnRH Antagonist: A 12-month, Multicentre, Randomized, Maintenance Dose-finding Phase II Study in Japanese Patients with Prostate Cancer |
scientific article published on March 28, 2012 |
Statements
1 reference
The efficacy and safety of degarelix, a GnRH antagonist: a 12-month, multicentre, randomized, maintenance dose-finding phase II study in Japanese patients with prostate cancer (English)
1 reference
The Efficacy and Safety of Degarelix, a GnRH Antagonist: A 12-month, Multicentre, Randomized, Maintenance Dose-finding Phase II Study in Japanese Patients with Prostate Cancer (English)
1 reference
Taiji Tsukamoto
1 reference
Seiichiro Ozono
1 reference
Takeshi Ueda
1 reference
Senji Hoshi
1 reference
Akito Yamaguchi
1 reference
Yuji Fukuyama
1 reference
Kentaro Takeda
1 reference
Yasuo Ohashi
1 reference
Seiji Naito
1 reference
Hideyuki Akaza
1 reference
28 March 2012
1 reference
1 reference
42
1 reference
6
1 reference
477-484
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference